From NASDAQ.: 2025-02-09 11:15:00

Equity markets had a strong January, but long-term investors should focus on companies with strong performance over time. Two biotech stocks, Vertex Pharmaceuticals and Moderna, have seen different movements this year. Vertex Pharmaceuticals received FDA approval for a non-opioid pain inhibitor, leading to share price increases. Moderna, known for its COVID-19 vaccine, has seen declining financial results post-pandemic but continues to innovate with new vaccine developments. Both companies have promising pipelines and potential for growth, making them intriguing options for investors willing to hold onto their stocks for the long term.



Read more at NASDAQ.: 2 Biotech Stocks to Buy Hand Over Fist in February